Oramed Pharmaceuticals Inc. — Director's Dealing 2012

Aug 9, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP.OB)
CIK: 0001176309
Period of Report: 2012-08-08

Reporting Person: Zommer Yifat Hen (CFO, TREASURER AND SECRETARY)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-08	Stock Option (right to buy)	$0.34	A	609000	Acquired	2012-08-08	Common Stock (609000)	Direct

Footnotes

F1: 21,000 will vest on the last day of each month commencing August 31, 2012 and ending on December 31, 2014.